In the latest trading session, 3.79 million Hims & Hers Health Inc (NYSE:HIMS) shares changed hands as the company’s beta touched 1.28. With the company’s most recent per share price at $26.30 changing hands around $0.1 or 0.38% at last look, the market valuation stands at $5.71B. HIMS’s current price is a discount, trading about -33.16% off its 52-week high of $35.02. The share price had its 52-week low at $8.09, which suggests the last value was 69.24% up since then. When we look at Hims & Hers Health Inc’s average trading volume, we note the 10-day average is 14.13 million shares, with the 3-month average coming to 16.65 million.

Analysts gave the Hims & Hers Health Inc (HIMS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.20. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 5 recommended HIMS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Hims & Hers Health Inc’s EPS for the current quarter is expected to be 0.22.

Hims & Hers Health Inc (NYSE:HIMS) trade information

Instantly HIMS is in green as seen in intraday trades today. With action -15.84%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 195.51%, with the 5-day performance at -15.84% in the red. However, in the 30-day time frame, Hims & Hers Health Inc (NYSE:HIMS) is 8.90% up. Looking at the short shares, we see there were 42.62 million shares sold at short interest cover period of 1.73 days.

The consensus price target for the stock as assigned by Wall Street analysts is 23, meaning bulls need a downside of -14.35% from its recent market value. According to analyst projections, HIMS’s forecast low is 18 with 38 as the target high. To hit the forecast high, the stock’s price needs a -44.49% plunge from its current level, while the stock would need to tank 31.56% for it to hit the projected low.

Hims & Hers Health Inc (HIMS) estimates and forecasts

Data shows that the Hims & Hers Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 13.56% over the past 6 months, a 600.00% in annual growth rate that is considerably higher than the industry average of 24.80%. Year-over-year growth is forecast to reach 67.55% up from the last financial year.

Consensus estimates given by 11 financial analysts project the company’s revenue in the current quarter to hit an average of 469.49M. 8 analysts are of the opinion that Hims & Hers Health Inc’s revenue for the current quarter will be 481.62M. The company’s revenue for the corresponding quarters a year ago was 246.62M and 278.17M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 90.37%. The estimates for the next quarter sales put growth at 73.14%.

The 2024 estimates are for Hims & Hers Health Inc earnings to increase by 824.74%.

HIMS Dividends

Hims & Hers Health Inc is expected to release its next quarterly earnings report in January.

Hims & Hers Health Inc (NYSE:HIMS)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 11.44% of Hims & Hers Health Inc shares while 65.34% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 73.77%. There are 65.34% institutions holding the Hims & Hers Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 7.7166% of the shares, roughly 16.47 million HIMS shares worth $332.55 million.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30.